Consultation on proposed commitments in respect of Vifor Pharma’s supply of intravenous iron

News Competition Consultations

Date: 10th Dec, 2024 Source: Competition and Markets Authority Country: United Kingdom Original Source

Brief

On 10/12/2024, the Competition and Markets Authority issued an update regarding Consultation on proposed commitments in respect of Vifor Pharma's supply of intravenous iron. The CMA invites views on commitments offered by Vifor Pharma to address concerns that it made potentially misleading claims about a competitor's treatment, Monofer, as compared to its own product, Ferinject.

This content is restricted.

Highlights content goes here...

This content is restricted.

Competition and Markets Authority

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Consultation on proposed commitments in respect of Vifor Pharma’s supply of intravenous iron

Brief

Competition and Markets Authority

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Consultation on proposed commitments in respect of Vifor Pharma’s supply of intravenous iron

Brief

Competition and Markets Authority

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.